Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142

Journal of Psychopharmacology

Volumn 16, Issue 2, 2002, Pages 125-131

  Dazzi, Laura ^a   Vignone, Vincenzo ^a   Seu, Emanuele ^a   Ladu, Stefania ^a   Vacca, Giada ^a   Biggio, Giovanni ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

FG 7142; Microdialysis; Norepinephrine; Prefrontal cortex; Venlafaxine

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; NORADRENALIN; VENLAFAXINE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CARBOLINE DERIVATIVE; CYCLOHEXANOL DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMOTION; LONG TERM EXPOSURE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRESS; TRANQUILIZING ACTIVITY; ANIMAL; ANXIETY; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; ELECTRIC SHOCK; EXTRACELLULAR SPACE; MENTAL STRESS; METABOLISM; MICRODIALYSIS; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT;

ANIMALS; ANXIETY; CARBOLINES; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EXTRACELLULAR SPACE; GABA AGONISTS; MALE; MICRODIALYSIS; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL;

EID: 0035986338     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600202     Document Type: Article

References (50)

1. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: Pharmacological and behavioral studies
2. Chronic stress increases serotonin and noradrenaline in rat brain and sensitizes their responses to a further acute stress
3. Role of locus coeruleus in attention and behavioral flexibility
4. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters
5. Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites
6. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat
7. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies
8. Forebrain norepinephrine: Role in controlled information processing in the rat
9. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat
10. β-carbolines enhance shock-induced suppression of drinking in rats
11. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder
12. Chronic antidepressant drugs antagonize stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats
13. Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs
14. Inhibition of stress- or anxiogenic drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs
15. Long-term treatment with antidepressant drugs reduces the sensitivity of cortical cholinergic neurons to the activating actions of stress and the anxiogenic drug FG 7142
16. Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors
17. Mirtazapine: Other indications
18. Mirtazapine in major depression with comorbid generalized anxiety disorder
19. Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat
20. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex
21. Anxiety disorders
22. Initial symptom levels and the life-event-depression relationship
23. The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment
24. Sensitization of norepinephrine activity following acute and chronic footshock
25. Single-unit and physiological analyses of brain norepinephrine function in behaving animals
26. Role of serotonin in depression
27. Mood disorders I: Major depressive disorders
28. Effect of novel environmental stimuli on rat behaviour and central noradrenaline function measured by in vivo microdialysis
29. Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats
30. Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction
31. Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus
32. The functional anatomy, neurochemistry and pharmacology of anxiety
33. Benzodiazepine receptor-mediated experimental 'anxiety' in primates
34. Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor
35. Anxiety and depression: A common neurobiological substrate?
36. Recurrent depression and stressful life events
37. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
38. Single unit activity of locus coeruleus neurons in freely moving cat - II. Conditioning and pharmacological studies
39. Single unit activity of locus coeruleus neurons in freely moving cat - I. During naturalistic behaviors and in response to simple and complex stimuli
40. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorders
41. Central norepinephrine neurons and behavior
42. Stress increases noradrenaline release in the rat frontal cortex: Prevention by diazepam
43. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects
44. Current concepts in the treatment of panic disorder
45. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety
46. Stress and antidepressants differently regulate neurotrophin 3 mRNA expression in the locus coeruleus
47. Mirtazapine vs. selective serotonin reuptake inhibitors
48. Antidepressant actions on brain noradrenergic neurons